ADICET BIO ORD
CUSIP: 007002207
ADICET BIO ORD (ACET) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
Adicet Bio is a clinical-stage biotechnology company developing allogeneic, off-the-shelf T cell therapies, with a focus on engineered gamma-delta T cells and CAR-T approaches for oncology and immune-mediated diseases. The company leverages proprietary cell engineering platforms to create standardized, donor-derived products intended to overcome limitations of autologous therapies. As a small clinical-stage firm it competes in the broader immuno-oncology and cell therapy sector against other developers of next-generation and allogeneic cell therapies.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
Try asking...